NCT06890013View on ClinicalTrials.gov

A Prospective, Single-center, Observational Study Aiming to Assess the Predictive Role of Flow Mediated Dilatation in Acute Coronary Syndromes, Combined With Echocardiographic and Biochemical Indices: The Novel Cor-IS Technology Will Also be Evaluated

RecruitingOBSERVATIONAL

Enrollment

100

Participants

Timeline

Start Date

June 1, 2024

Primary Completion Date

June 1, 2026

Study Completion Date

November 1, 2026

Conditions

Acute Coronary SyndromesFlow Mediated DilationEndothelial Function (FMD)

Interventions

DIAGNOSTIC_TEST

Observation group

Patients with acute coronary syndrome undergo endothelial function assessment using two methods (flow mediated dilatation of the brachial artery and Cor-Is technology) transthoracic echocardiogram and plasma biomarkers' measurement.

Trial Locations (1)

54642

RECRUITING

Ippokratio General Hospital, Thessaloniki

All Listed Sponsors

lead

Aristotle University Of Thessaloniki

OTHER